In conclusion, we identified PRMT5 as a novel marker for predicting the prognosis of pancreatic cancer and reported its novel role in regulating aerobic glycolysis via the FBW7/cMyc axis. This evidence concerns the gene FBXW7 and familial pancreatic carcinoma.